Age-dependent neuroprotection of retinal ganglion cells by tempol-C8 acyl ester in a rat NMDA toxicity model

Standard

Age-dependent neuroprotection of retinal ganglion cells by tempol-C8 acyl ester in a rat NMDA toxicity model. / Fiedorowicz, Michal; Rejdak, Robert; Schuettauf, Frank; Wozniak, Michal; Grieb, Pawel; Thaler, Sebastian.

In: FOLIA NEUROPATHOL, Vol. 52, No. 3, 2014, p. 291-7.

Research output: SCORING: Contribution to journalSCORING: Journal articleResearchpeer-review

Harvard

APA

Vancouver

Bibtex

@article{eda66f8e4d214cc1a570a12999b39437,
title = "Age-dependent neuroprotection of retinal ganglion cells by tempol-C8 acyl ester in a rat NMDA toxicity model",
abstract = "BACKGROUND: The efficacy of tempol and its acyl derivative tempol-C8 as retinoprotective agents was compared in a rat model of NMDA-induced retinal ganglion cell (RGC) damage.MATERIAL AND METHODS: Tempol or tempol-C8 in different doses was administered intraperitoneally to 6 weeks old (pre-adolescent) and 9-10 weeks old (young adult) rats before and after an intravitreous NMDA injection. Retinal ganglion cell were retrogradely labeled with the fluorescent tracer hydroxystilbamidine and RGC counting was performed on retinal flatmounts.RESULTS: Intravitreal NMDA reduced RGC counts by about 90%, independently of age < 0.001). In pre-adolescent animals tempol-C8, but not tempol unmodified, showed a significant, dose-dependent RGC rescue effect, with peak activity at 5.8 µmol/kg (p < 0.001). In young adult animals, however, no neuroprotective effect was found for either tempol or tempol-C8.CONCLUSIONS: In contrast to tempol itself, tempol-C8 acyl ester was neuroprotective in pre-adolescent rats in the NMDA- induced RGC damage model. Therefore, neuroprotection by tempol acyl esters seems to be superior to that of tempol under certain conditions.",
keywords = "Aging, Animals, Cyclic N-Oxides/pharmacology, Disease Models, Animal, Excitatory Amino Acid Agonists/toxicity, N-Methylaspartate/toxicity, Neuroprotective Agents/pharmacology, Rats, Retinal Ganglion Cells/drug effects, Spin Labels",
author = "Michal Fiedorowicz and Robert Rejdak and Frank Schuettauf and Michal Wozniak and Pawel Grieb and Sebastian Thaler",
year = "2014",
doi = "10.5114/fn.2014.45570",
language = "English",
volume = "52",
pages = "291--7",
journal = "FOLIA NEUROPATHOL",
issn = "1641-4640",
publisher = "Termedia Publishing House Ltd.",
number = "3",

}

RIS

TY - JOUR

T1 - Age-dependent neuroprotection of retinal ganglion cells by tempol-C8 acyl ester in a rat NMDA toxicity model

AU - Fiedorowicz, Michal

AU - Rejdak, Robert

AU - Schuettauf, Frank

AU - Wozniak, Michal

AU - Grieb, Pawel

AU - Thaler, Sebastian

PY - 2014

Y1 - 2014

N2 - BACKGROUND: The efficacy of tempol and its acyl derivative tempol-C8 as retinoprotective agents was compared in a rat model of NMDA-induced retinal ganglion cell (RGC) damage.MATERIAL AND METHODS: Tempol or tempol-C8 in different doses was administered intraperitoneally to 6 weeks old (pre-adolescent) and 9-10 weeks old (young adult) rats before and after an intravitreous NMDA injection. Retinal ganglion cell were retrogradely labeled with the fluorescent tracer hydroxystilbamidine and RGC counting was performed on retinal flatmounts.RESULTS: Intravitreal NMDA reduced RGC counts by about 90%, independently of age < 0.001). In pre-adolescent animals tempol-C8, but not tempol unmodified, showed a significant, dose-dependent RGC rescue effect, with peak activity at 5.8 µmol/kg (p < 0.001). In young adult animals, however, no neuroprotective effect was found for either tempol or tempol-C8.CONCLUSIONS: In contrast to tempol itself, tempol-C8 acyl ester was neuroprotective in pre-adolescent rats in the NMDA- induced RGC damage model. Therefore, neuroprotection by tempol acyl esters seems to be superior to that of tempol under certain conditions.

AB - BACKGROUND: The efficacy of tempol and its acyl derivative tempol-C8 as retinoprotective agents was compared in a rat model of NMDA-induced retinal ganglion cell (RGC) damage.MATERIAL AND METHODS: Tempol or tempol-C8 in different doses was administered intraperitoneally to 6 weeks old (pre-adolescent) and 9-10 weeks old (young adult) rats before and after an intravitreous NMDA injection. Retinal ganglion cell were retrogradely labeled with the fluorescent tracer hydroxystilbamidine and RGC counting was performed on retinal flatmounts.RESULTS: Intravitreal NMDA reduced RGC counts by about 90%, independently of age < 0.001). In pre-adolescent animals tempol-C8, but not tempol unmodified, showed a significant, dose-dependent RGC rescue effect, with peak activity at 5.8 µmol/kg (p < 0.001). In young adult animals, however, no neuroprotective effect was found for either tempol or tempol-C8.CONCLUSIONS: In contrast to tempol itself, tempol-C8 acyl ester was neuroprotective in pre-adolescent rats in the NMDA- induced RGC damage model. Therefore, neuroprotection by tempol acyl esters seems to be superior to that of tempol under certain conditions.

KW - Aging

KW - Animals

KW - Cyclic N-Oxides/pharmacology

KW - Disease Models, Animal

KW - Excitatory Amino Acid Agonists/toxicity

KW - N-Methylaspartate/toxicity

KW - Neuroprotective Agents/pharmacology

KW - Rats

KW - Retinal Ganglion Cells/drug effects

KW - Spin Labels

U2 - 10.5114/fn.2014.45570

DO - 10.5114/fn.2014.45570

M3 - SCORING: Journal article

C2 - 25310740

VL - 52

SP - 291

EP - 297

JO - FOLIA NEUROPATHOL

JF - FOLIA NEUROPATHOL

SN - 1641-4640

IS - 3

ER -